Genome editing-based therapies become the predominant technology of the 21st century with promising statements about genetic diseases treatments. Genome editing tools recently emerged but they suffer from an absence of standardization and their applications remain limited.
In this context, Quidditas developed a novel genome editing platform which permits an absolute genetic recombination.
Compatible with a larger scope of applications, from bioprocess improvement to genetic disorders treatment, this revolutionary technique will have a major impact in the synthetic Bio field.

So “Let’s cure from the beginning!”

QUIDDITAS

Org chart

Teams

Offices

QUIDDITAS

Org chart

Teams

Offices

Related companies